Spiden
Signal active
Organization
Contact Information
Overview
Spiden develops an optical + AI based technology to analyse blood, urine and other body fluids for the first time non-destructively and in real-time.
About
Industries
Biotechnology, Artificial Intelligence (AI)
Founded
2017
Employees
11-50
Headquarters locations
Switzerland, Europe
Social
N/A
Profile Resume
Spiden headquartered in Switzerland, Europe, operates in the Biotechnology, Artificial Intelligence (AI) sector. The company focuses on Biotechnology and has secured $966.0M in funding across 24 round(s). With a team of 11-50 employees, Spiden is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Spiden, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$40.3M
Details
2
Spiden has raised a total of $40.3M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Seed | 7.3M | ||
| 2021 | Seed | 18.0M |
Investors
Spiden is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| b2venture | - | FUNDING ROUND - b2venture | 18.0M |
| Edward Ludwig | - | FUNDING ROUND - Edward Ludwig | 18.0M |
| Spiden | - | FUNDING ROUND - Spiden | 18.0M |
| Kirill Evstratov | - | FUNDING ROUND - Kirill Evstratov | 18.0M |
Recent Activity
There is no recent news or activity for this profile.